The GOG partners: A program for industry sponsored clinical trials in gynecologic oncology within the GOG foundation

The GOG Foundation, Inc. (GOG-F) is a non-profit 501(c)(3) organization with the purpose of promoting excellence in the quality and integrity of clinical and basic scientific research in the field of gynecologic malignancies. GOG Partners (GOG-P) is a program of the GOG-F and is positioned alongside NRG Oncology under the GOG-F organizational umbrella. GOG-P operates outside of the federally funded NCI NRG Oncology, a key distinguishing feature. By functioning as a site management organization (SMO), GOG-P provides an additional platform for clinical trial development, mentorship opportunities, patient accrual, and site infrastructure support yielding an expanded gynecologic oncology clinical trials infrastructure in the US. GOG-P has a consistent track record of conducting high quality clinical trials that lead to bringing novel FDA approved treatments for gynecologic cancer. This manuscript summarizes the history and organizational structure of the GOG-P. In addition, we outline the other key supportive programs within the GOG-F that help support the GOG-P effort to perform transformative gynecologic cancer research. •The GOG Foundation is a nonprofit organization promoting excellence in clinical and basic scientific research.•The GOG Foundation supports clinical trial development, mentorship, patient accrual and site infrastructure support.•GOG Partners is a component of the GOG Foundation and is structured to conduct clinical trials funded by industry sponsors.•GOG Partners expands the US gynecologic oncology clinical trials network via its function as a site management organization.